DK0539525T3 - Vitalethein og anvendelse deraf i cellekultur og terapi - Google Patents

Vitalethein og anvendelse deraf i cellekultur og terapi

Info

Publication number
DK0539525T3
DK0539525T3 DK91915854T DK91915854T DK0539525T3 DK 0539525 T3 DK0539525 T3 DK 0539525T3 DK 91915854 T DK91915854 T DK 91915854T DK 91915854 T DK91915854 T DK 91915854T DK 0539525 T3 DK0539525 T3 DK 0539525T3
Authority
DK
Denmark
Prior art keywords
vitalethein
therapy
cell culture
vitaletheine
cell
Prior art date
Application number
DK91915854T
Other languages
Danish (da)
English (en)
Inventor
Galen Daryl Knight
Terence Joseph Scallen
Original Assignee
Univ New Mexico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New Mexico filed Critical Univ New Mexico
Application granted granted Critical
Publication of DK0539525T3 publication Critical patent/DK0539525T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0025Culture media for plant cell or plant tissue culture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • C12N2500/33Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91915854T 1990-07-06 1991-07-08 Vitalethein og anvendelse deraf i cellekultur og terapi DK0539525T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54944090A 1990-07-06 1990-07-06
US54910590A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
PCT/US1991/004726 WO1992000955A1 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Publications (1)

Publication Number Publication Date
DK0539525T3 true DK0539525T3 (da) 2000-04-10

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915854T DK0539525T3 (da) 1990-07-06 1991-07-08 Vitalethein og anvendelse deraf i cellekultur og terapi

Country Status (9)

Country Link
EP (1) EP0539525B1 (https=)
JP (1) JP3259960B2 (https=)
AT (1) ATE186048T1 (https=)
AU (1) AU655598B2 (https=)
DE (1) DE69131752T2 (https=)
DK (1) DK0539525T3 (https=)
ES (1) ES2139580T3 (https=)
GR (1) GR3031801T3 (https=)
WO (1) WO1992000955A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007819A (en) * 1995-10-17 1999-12-28 Dovetail Technologies, Inc. Methods of inducing immunity using low molecular weight immune stimulants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
ES2080954T3 (es) * 1990-07-06 1996-02-16 Univ New Mexico Uso de beta-aletina en cultivos de celulas y en terapia.

Also Published As

Publication number Publication date
WO1992000955A1 (en) 1992-01-23
ATE186048T1 (de) 1999-11-15
JP3259960B2 (ja) 2002-02-25
GR3031801T3 (en) 2000-02-29
AU655598B2 (en) 1995-01-05
DE69131752D1 (de) 1999-12-02
EP0539525B1 (en) 1999-10-27
EP0539525A4 (https=) 1994-01-12
JPH06500106A (ja) 1994-01-06
AU8500891A (en) 1992-02-04
DE69131752T2 (de) 2000-06-29
HK1014367A1 (en) 1999-09-24
EP0539525A1 (en) 1993-05-05
ES2139580T3 (es) 2000-02-16

Similar Documents

Publication Publication Date Title
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
DE60009956D1 (de) Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium
BR9910251A (pt) Estimulação hematopoiética
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
FI920430A0 (fi) Benzyloxifenylderivator.
PT809437E (pt) Tiois para promover crescimento de celulas progenitoras hematopoieticas
PT862452E (pt) Formulacao de estabilizacao para o ngf
EP0380692A4 (en) Plant tissue culture process
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
DK0539525T3 (da) Vitalethein og anvendelse deraf i cellekultur og terapi
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
ATE124262T1 (de) Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
PT883406E (pt) Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente
FR2835429B1 (fr) Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos